Stéphanie Lheureux

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab

Scott V. Bratman, S.Y. Cindy Yang, Marco Iafolla et al. · Nature Cancer · 2020 · 466 citations

Prognostic Biomarkers, Tumor Dna Analysis, Medicine +11

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

S.Y. Cindy Yang, Scott Lien, Ben X. Wang et al. · Nature Communications · 2021 · 125 citations · Full text

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors

S.Y. Cindy Yang, Stéphanie Lheureux, Katherine Karakasis et al. · Genome Medicine · 2018 · 107 citations · Full text

Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy

Nicolas Vigneron, Matthieu Meryet‐Figuière, Audrey Guttin et al. · Molecular Oncology · 2016 · 81 citations · Full text

Engineering, Pathology, Mirnas Profiling +21

F18-Choline, a Novel PET Tracer for Parathyroid Adenoma?

Elske Quak, Stéphanie Lheureux, Yves Reznik et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 79 citations

Parathyroid Disease, Pathology, Parathyroid Gland +16